GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Deferred Tax

BioHarvest Sciences (XCNQ:BHSC) Deferred Tax : C$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

BioHarvest Sciences's change in deferred tax for the three months ended in Jun. 2024 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00 Mil.

BioHarvest Sciences Deferred Tax Historical Data

The historical data trend for BioHarvest Sciences's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Deferred Tax Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioHarvest Sciences Quarterly Data
Jul19 Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioHarvest Sciences Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Deferred Tax Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Deferred Tax
Comparable Companies
TSXV:FRSH XCNQ:BOIL TSX:SWP TSX:BABY XCNQ:MOOO XCNQ:HBFG XCNQ:BITE TSX:BU NEOE:NGRB XCNQ:GFCO XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
CNVCD:USA 8MV0:Germany
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
Website
https://www.bioharvest.com
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences Headlines

No Headlines